Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data (Q34258885)

1 August 2017

Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data (English)

1 reference

1 August 2017

0 references

1 reference

Joaquim Gascon

10

0 references

J. Erin Staples

2

object named as

J Erin Staples

1 reference

1 August 2017

24

Katrin S Kohl

1 reference

1 August 2017

19

Matthias Niedrig

1 reference

1 August 2017

9

Anna Durbin

1 reference

1 August 2017

Mark D Gershman

1

1 reference

1 August 2017

Adwoa D Bentsi-Enchill

3

1 reference

1 August 2017

J Gabrielle Breugelmans

4

1 reference

1 August 2017

Glacus S Brito

5

1 reference

1 August 2017

Luiz Antonio Bastos Camacho

6

1 reference

1 August 2017

Pascale Cottin

7

1 reference

1 August 2017

Cristina Domingo

8

1 reference

1 August 2017

Fouzia Guenaneche

11

1 reference

1 August 2017

Edward B Hayes

12

1 reference

1 August 2017

Zsuzsanna Jelenik

13

1 reference

1 August 2017

Alena Khromava

14

1 reference

1 August 2017

Reinaldo de Menezes Martins

15

1 reference

1 August 2017

Mario Masana Wilson

16

1 reference

1 August 2017

Nathalie Massy

17

1 reference

1 August 2017

Abdulsalami Nasidi

18

1 reference

1 August 2017

Adam Sherwat

20

1 reference

1 August 2017

Theodore Tsai

21

1 reference

1 August 2017

Anna Vilella

22

1 reference

1 August 2017

Mary Elizabeth Wilson

23

1 reference

1 August 2017

Brighton Collaboration Viscerotropic Disease Working Group

25

1 reference

1 August 2017

language of work or name

English

0 references

publication date

4 May 2012

1 reference

1 August 2017

1 reference

1 August 2017

30

1 reference

1 August 2017

33

1 reference

1 August 2017

5038-5058

1 reference

Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: a prospective controlled cohort study

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Infant meningoencephalitis caused by yellow fever vaccine virus transmitted via breastmilk

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

A Case of Yellow Fever Vaccine-Associated Viscerotropic Disease in Ecuador

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Transmission of yellow fever vaccine virus through breast-feeding - Brazil, 2009.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Viscerotropic disease following yellow fever vaccination in Peru

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Raising awareness of chronic kidney disease in a Brazilian urban population

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Complications associated with sickle cell trait: a brief narrative review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Adverse event reports following yellow fever vaccination

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Thrombocytopenia: case definition and guidelines for collection, analysis, and presentation of immunization safety data

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Yellow fever vaccine-associated viscerotropic disease and death in Spain.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Rare case of fatal yellow fever vaccine-associated viscerotropic disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Risk of fatal adverse events associated with 17DD yellow fever vaccine.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

CIRCULATING VIRUS, INTERFERON AND ANTIBODY AFTER VACCINATION WITH THE 17-D STRAIN OF YELLOW-FEVER VIRUS.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Adverse events associated with 17D-derived yellow fever vaccination--United States, 2001-2002.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

28 July 2018

Yellow fever: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

28 July 2018

Rhabdomyolysis: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Urinary tract morbidity in schistosomiasis haematobia: associations with age and intensity of infection in an endemic area of Coast Province, Kenya

28 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

28 July 2018

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.067

Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

7 January 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

A live, attenuated recombinant West Nile virus vaccine

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

History of thymoma and yellow fever vaccination

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Effects of yellow fever vaccination

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part I: definition, detection, prevalence, and etiology

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Disseminated infection with varicella-zoster virus vaccine strain presenting as hepatitis in a child with adenosine deaminase deficiency

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425393

Effects of yellow fever vaccination

28 October 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.067

Effects of yellow fever vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.067

Yellow Fever Vaccine Post-marketing Surveillance in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.067

The development of standardized case definitions and guidelines for adverse events following immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.067

Varicella vaccination in a child with acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.067

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.067

The public health significance of urinary schistosomiasis as a cause of morbidity in two districts in Mali

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.067

Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.067

7 January 2021

1 reference

12 December 2020

Fatal disseminated infection due to poliovirus type 2 vaccine

1 reference

PubMed

12 December 2020

Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting

1 reference

PubMed

12 December 2020

Yellow fever surveillance and outbreak response: revision of case definitions, October 2010

1 reference

PubMed

12 December 2020

10.1016/J.VACCINE.2012.04.067

Identifiers

DOI

1 reference

1 August 2017

1 reference

1 August 2017

1 reference